With nearly 9 million people living with type 1 diabetes (T1D) across the globe, it is one of the fastest-growing non-communicable conditions today.
The T1D Index is a first of its kind data simulation tool that measures and maps the human and public health impact of T1D. The Index uniquely illuminates the human burden of T1D by highlighting โmissing peopleโ and โhealthy years lostโ to the condition.
T1D has a profound human, emotional, and financial burden for those who live with it – and that burden is rising rapidly. However, simulations from the T1D Index have identified four key interventions that could change the current trajectory of T1D and its impact on people around the world. The T1D Index helps shine a light on the challenges we face, giving us a chance to act now.
How was the T1D Index developed?
The simulation is informed by 400+ publications around the globe (dating back to 1890) and a global survey of more than 500 endocrinologists. These data sources have been fitted to mathematical and machine-learning models that speak to:
Rates of new cases
The risk of complications and mortality
Prevailing standards of medical care
The T1D Index simulations provide the most accurate estimate of T1D currently available with version 1.0 testing to +/- 6 percent against real-world data. This is a significant improvement from leading existing estimates that test to +/- 35 percent against the same data.
The T1D Index and accompanying research has been published in one of the most trusted medical journals, The Lancet Diabetes and Endocrinology.
This work is the basis for a publicly available, open-source model that will be updated annually as further incidence, prevalence, and mortality data become available. In future releases, the Index will expand to include T1Dโs impact on economic costs, mental health, and quality of life. The data will also be broken down at regional and demographic levels.
If you have ideas or data that may improve the T1D Index, please let us know at hello@t1dindex.org and sign up to be involved in future model development.
Whoโs behind the T1D Index?
The Index was developed collaboratively by Breakthrough T1D, Life for a Child, International Society for Pediatric and Adolescent Diabetes (ISPAD), International Diabetes Federation (IDF).
These organizations represent part of the diverse global diabetes community, and this coalition is committed to working together to expand this partnership.
Our aim is to provide robust, credible data that inspires action and helps save and improve innumerable lives.
Founding T1D Index Partners
Breakthrough T1D is the leading global organization harnessing the power of research, advocacy, and community engagement to advance life-changing breakthroughs for type 1 diabetes (T1D).
โAs a member of the T1D community, I know many are not as fortunate as I am to have the resources necessary to live a healthy and fulfilled life. This is why I am so proud that significant progress has been made to understand T1Dโs global impact through the T1D Index. We are calling on government and public health decision makers throughout the world to utilize the tool to identify and implement interventions that can change the trajectory of T1D.โ
Life for a Child supports children and young people living with diabetes in under-resourced communities. They partner with local clinics in 44 countries and work to ensure every young person has access to the insulin and supplies they need. Life for a Childโs vision statement is, โNo child should die of diabetes.โ
โIt is critical to know the number of people with T1D so that sufficient resources are allocated and advocacy efforts optimized. In this regard, the T1D Index is a truly novel initiative with enormous promise. It builds on the modeling work developed by Life for a Child and the University of Pittsburgh, as well as the work behind the IDF Atlas, a global survey by ISPAD, and various other data sources. Breakthrough T1Dโs inputs of a larger vision, advanced statistical methods and new ways of looking at the situation, have led to a robust method of generating information on current and projected future situations concerning T1D at all ages for all countries. The Index will also be able to model the impact of proposed interventions. The open-source nature greatly enhances the usability. Life for a Child is providing extensive technical guidance and support, and will continue to do this as the Index develops.โ
The International Diabetes Federation (IDF) is an umbrella organization of over 240 national diabetes associations in 160 countries and territories. IDF is engaged in action to tackle diabetes from the local to the global level, representing the interests of the growing number of people with diabetes and those at risk.
โMore than 100 years have passed since the first successful use of therapeutic insulin. It shames the world that early diagnosis and access to appropriate standards of care are still not universally achieved. Providing the evidence is key to helping the global diabetes community to raise awareness and demand action to bring about the increased investment in access, treatment, and prevention that is required.
The launch of the Index is timely and welcome. It places an innovative tool in the hands of diabetes advocates everywhere. It will help reframe the argument around access to care for people living with T1D and draw attention to the significant disparities that continue to exist globally.
The International Diabetes Federation (IDF) is delighted to have contributed to the development of the Type 1 Diabetes Index and will support its promotion and further development to make the case for uninterrupted access to affordable insulin, along with the technologies and education that support successful insulin therapy for all people living with T1D.โ
ISPAD is the International Society for Pediatric and Adolescent Diabetes. The mission of ISPAD is to create a better world for children, adolescents, and young adults with diabetes. Additionally, ISPAD, in partnership with Breakthrough T1D, funds the annual Allan Drash Clinical Fellowship, which gives members based in developing and middle income countries the opportunity to expand their clinical experience in diabetes management.
โThe T1D Index is a powerful resource. It provides the metrics on type 1 diabetes to advocate and drive change with our partners and the community. The index highlights the disparities and needs of those with T1D around the world. Lives are lost, and days lost due to diabetes, its burden of care and its complications. ISPAD, the International Society for Pediatric and Adolescent Diabetes with a global membership of over 1,100 members in 107 countries, has been delighted to work on this project. It has developed and enabled the survey โThe Global State of T1Dโ with Breakthrough T1D and LFAC, contributing to the numbers with diabetes, the numbers undiagnosed and thus lost; and the time lost to type 1 diabetes and its care in our member countries. We look forward to the next phase of action with the T1D Index with our partners.โ
Other Partners
Foundation Partner
The Leona M. and Harry B. Helmsley Charitable Trust is a global philanthropy organization committed to helping people live better lives today and creating stronger, healthier futures for individuals and communities.
โIn too many places, T1D is an invisible disease, not on the radar of the healthcare community and often diagnosed only when itโs too late. The T1D Index is an important step in adding visibility to T1D, and offering a base on which to build data-driven interventions that can better support the T1D community in low- and middle-income countries.โ
Founding Corporate Partner
Abbott is a global healthcare leader that helps people live more fully at all stages of life. The companyโs portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals, and branded generic medicines.
“The best healthcare solution is the one that helps the most people. New data and insights generated from the T1D Global Index show how early access to the latest technologies, such as FreeStyle Libre continuous glucose monitoring systems, can help people living with Type 1 diabetes live a longer, fuller, and healthier life.”
T1D IndexCorporate Sponsor
Lilly has been a global leader in diabetes care since 1923, when they introduced the world’s first commercial insulin. Today Lilly is building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing Lilly strives to make life better for people affected by diabetes and related conditions. Lilly is working to deliver breakthrough outcomes through innovative solutionsโfrom medicines and technologies to support programs and more.
“Lilly is a proud supporter of Breakthrough T1Dโs Global T1D Index, as we collaborate to help people around the globe live longer, healthier lives. The Index has the potential to revolutionize the diagnosis and treatment of Type 1 Diabetes by substantially improving our understanding of the prevalence and incidence of Type 1 โ and using that data to save millions of lives. In developed countries, this means improving access to care, increasing clinical trial diversity, and advancing research, all priorities Lilly shares. This platform has particular promise in resource-limited countries by improving diagnosis, promoting improved, integrated care and advancing affordability across diabetes care. Lilly is committed to these goals through programs such as our long-term partnership with Life for a Child to build sustainable diabetes care models for vulnerable populations. We look forward to working with Breakthrough T1D and T1D Index partners to advance this vision, ensuring no child or individual dies of diabetes no matter where they live.”
Global Access Corporate Partner
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) โ a rare, life-threatening genetic disease โ and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.
โVertex is proud to support Breakthrough T1Dโs Global Access Initiative, including todayโs launch of the Global T1D Index. For far too long, our understanding about the extent and impact of type 1 diabetes has been limited due to incomplete or inaccurate data. The launch of the T1D Index is a pivotal moment for the T1D community and will enable and inspire action to improve the lives of people with T1D throughout the world.โ
โAccess to diabetes care in Brazil has improved a lot in the past two decades, but the T1D Index helps us to see that there is still room for improving a lot, with equitable access to medicines and supplies associated to trained multidisciplinary healthcare teams and structured diabetes education.โ
“The World Diabetes Foundation is a leading global funder of diabetes prevention and care projects in low- and middle-income countries. Our vision is to alleviate human suffering related to diabetes among those in greatest need – since 2002, we have provided 182 million euros in funding to 584 partnership projects in 119 countries. Many of our projects have focused on type 1 diabetes and we are currently supporting children with type 1 diabetes through the Changing Diabetes in Children Programme in eight countries along with other type 1-focused projects. Through our work and experience we fully recognise the need for improved data on patients with type 1 diabetes and therefore welcome the T1D Index and look forward to engaging with Breakthrough T1D and other key stakeholders on these issues.”
“We are delighted to be able to contribute to the T1D index. I led the work on the recent systematic review on incidence of type 1 diabetes in adults for the IDF Diabetes Atlas. This highlighted the paucity of data on type 1 diabetes in adults, as well as the surprisingly high rates in late adulthood. The T1D index builds on the data collected from our systematic review, and provides a comprehensive estimate of the global burden of type 1 diabetes in different parts of the world. The T1D index highlights the urgent need to better identify adults presenting with diabetes who in fact have underlying T1D. It will no doubt be an invaluable resource for healthcare professionals as well as health organizations for advocacy and healthcare planning.”
โData from the T1D index will demonstrate to country decision makers how better access to diagnostics and self-monitoring tools can save health systems money and improve quality of life for people living with diabetes.โ
“The availability of the Type 1 Diabetes (T1D) Index is a wake-up call for the Low and Middle Income Countries (LMIC) that now there is a rich resource of data and tools to handle the epidemiology and quality management of T1D in these countries.”
โThe Brazilian Diabetes Society considers the T1D Index a milestone in the knowledge of T1D epidemiology worldwide. The information on real numbers of people with T1D and days/lives lost to diabetes will bring awareness and allow the development of policies aimed to reduce the current discrepancies and to improve the quality of diabetes care offered today.โ
“I was very proud to be able to share my expertise on diabetes and particularly type 1 diabetes in Africa with the team that developed the TD1 index, which is an extraordinary tool. The team was also able to use our published work on the prevalence and incidence of T1D in Mali to enrich T1D.”
“Data helps paint pictures – vivid pictures that are easy to understand and connect with. The T1D Index is bringing to life – finally! – the challenges that people with Type 1 diabetes face all over the world. As a South African with Type 1, I’m excited to see how this can advance our advocacy efforts so that we can improve the lives of people with Type 1 in SA.”
“Taking the first step, creating something from scratch, going from zero to one – is always the most challenging. What it yields is a foundation that others can build on and drive exponential growth. This is what we strongly believe at Diabesties, and I’m excited to see the same principle in action with the T1D Index. It is a much needed development that would allow governments, support organizations and broader stakeholders, to accurately understand the urgency that Type 1 Diabetes requires globally. As organizations and people living with the condition, we have continuously tried to raise the profile of T1D, but were missing this crucial piece of evidence. The T1D index captures poignant and powerful data which outlines key issues and metrics. I am confident that we would be able to use this data in multiple ways to improve the quality AND quantity of life for those living with T1D. The index not only helps understand the reality of disparity in access, but also serves as a tool to influence policy that can help make a meaningful and sustainable change. This comprehensive document is a major resource for the entire community and we at Diabesties, are grateful to be partners in this grand pursuit.”
โI wish to congratulate the authors of the T1D Index. This is the first such compilation internationally and shows the huge burden of type 1 diabetes in different parts of the world. I am particularly concerned that India has one of the largest numbers of T1D, both below, as well as, above 20 years of age. It is also worrying that the remaining life expectancy in those with T1D in India is only 24 years, compared to 69 years in Japan and 67 years in Australia. This points to the need for improving the control of T1D in developing countries like Indiaโ.
โThe T1D Index permits to finally understand and act on the challenges faced by people with type 1, their families, and communities globally and by country. I expect to see advocate and decision makers using it broadly to immediately start to improve the critical T1D situation.โ
“EUDF is proud to support the launch of the T1D Index. The T1D Index measures the human and public health impact of the T1D crisis in every country across the globe. EUDF will use these data and insights from the T1D index in our advocacy work with European policy makers. Greater awareness of the impact of T1D will help change the lives of people with T1D.”
“The T1D Index is a unique endeavor and the need of the hour to highlight type 1 diabetes as a global issue. It brings together T1D stakeholders worldwide and presents an opportunity to raise awareness in a unified voice. Together, we’re stronger. And this rings true especially in our mission to improve the quality of life for people living with diabetes worldwide.”
“I was very excited to be involved in the generation of the T1D Index. Understanding the burden of type 1 diabetes for the world to date has been challenging. Such information is crucial, not only to increase the awareness of type 1 diabetes, but also to inform public health policy, improve ย delivery of care and ultimately the quality of life for people with type 1 diabetes.”
“This is a most significant aid for type 1 diabetes advocacy and will assist any interested Parliamentarian now and into the future given the plan to keep it up to date with the latest data.”
“The T1D Index is an incredibly rich and compelling dataset on T1D globally. We are excited to collaborate with the team to further advance understanding of the burden of the disease and what can be done to improve care.”
โWe are extremely grateful to Breakthrough T1D for taking the leadership role in establishing the T1D Index which is going to provide tremendous visibility on the global picture as it relates to Type 1 Diabetes. As a result, we are convinced this will lead to a higher level of diagnosis, and enhanced ongoing treatment of the condition, ultimately leading to improved health outcomesย and saving hundreds and thousands of lives.โ
“I am a person living with T1D for the past 20 years & I volunteer at the Blue Circle Diabetes Foundation. I believe that people living with Diabetes should be empowered with proper education & engagement with local communities to create safe spaces so that they are able to voice their opinions & views.”
“TDYA is involved in educating the general public on Type 1 Diabetes in order that every young person with T1D should be able to live a healthy lifestyle, free of stigma, with controlled blood sugar levels, and achieve their goals in life.
We are developing education and training programs for primary and secondary schools, making use of the Mass media, organizing fund-raising activities, conducting regular youth leadership training camps, and peer-to-peer counseling centers, developing microfinance support for further education, and cooperating with the Ministry of Health.”
“Insulin for Life-USA has, for the last decade, dedicated itself to see that supplies essential for diabetes management are available to those in need within the developing world.ย Now, serving some 22 countries, this organization, “green in its operations”, is dedicated to saving lives and improving diabetes care for those that would otherwise go without”
โThe T1D Index permits to finally understand and act on the challenges faced by people with type 1, their families, and communities globally and by country. I expect to see advocate and decision makers using it broadly to immediately start to improve the critical T1D situation.โ
“The T1D Index is innovative in showing the real impact of T1Diabetes in people’s lives, and also will play a major role in providing extremely useful data, allowing countries to establish new policies to fight the burden and outcomes of the disease. I was very fortunate to be involved with the development of Brazilian data (via the Brazilian Diabetes Society) together with dear colleagues, and also working as an ISPAD Executive Board member, one of the partners of this initiative.”
“The T1D Index is a ground breaking project which for the first time has established the full extent of T1 diabetes. It provides important country level information which can be used to reduce the T1 burden for individuals, their family and the health system.”
Jeremiah B Cooper Liberia
Dr Carine de Beaufort Guest professor, Pediatric Diabetologist โEndocrinologist ISPAD President 2020-2022, Luxembourg Co-author
“ISPAD is a global scientific societyย with a focus on all forms of diabetes in children, adolescents and young adults. Its vision is to create a better world for this ย ย ย ย ย population. Active involvement of ISPAD membership has supported the development of the Global T1 Index. Now we need to move forward together to change and improve outcome, at diagnosis, treatment and prevention of acute and ย ย ย ย ย ย ย ย late complications.”
Professor Kim Donaghue The Children’s Hospital at Westmead and University of Sydney Australia Co-author
โAs then ISPAD President I became involved in this important work, in particular the development and facilitation of the Survey in 2020 with Breakthrough T1D on the Global State of Diabetes. This information is a powerful tool to drive change and awareness of the burden of diabetesโ.
Dr Ileana E Gill Co-founder Guerreros Azules Venezuela
“The T1D Index represents a once in a lifetime opportunity to put the most accurate real-time data in the hands of advocates and key stakeholders from across the globe. Harnessing the power of data and making it accessible to all, allows the T1D community to have an even louder voice and will help further their efforts to influence change. As a member of Breakthrough T1Dโs Global Access team, I am so unbelievably proud to be involved in this work and looking forward to what comes next.”
“Being a past president of ISPAD and current steering member of LFAC, I think it is vital to have accurate numbers of the incidence and prevalence of type 1 diabetes in youth. We need to know how common deaths are in order to find these individuals in time to give them proper care.”
“Living with type 1 diabetes for 25 years and working in the industry for seven, illustrative data drives every meaningful piece of my work. From collaborations on life-sustaining medications and tools to advocating for more equitable access to care, everything we are working toward is made stronger with accurate numbers that show the true impact of this disease across the world.”
“This is an admirable piece of work from Breakthrough T1D attempting to tackle a huge problem worldwide- and shining a light not only on the scale of the problem- but also with suggestions tailored to differentย countries. Its great to be involved with this- and hopefully this will help stimulate global improvement in T1D care”
โEvidence-based advocacy for T1D is for everyone, but the ins and outs of this type of advocacy are sometimes over complicated and inaccessible for the people who could use it most. The beauty of the T1D Index to me, is not just that it is the most compelling tool to date making the case for increased investment in global T1D care, but in its person-centered approach in which evidence-based advocacy is democratized for anyone to use.โ
George Kwayu Chairman, Tanzania Diabetes Youth Alliance Tanzania
“TDYA is involved in educating the general public on Type 1 Diabetes in order that every young person with T1D should be able to live a healthy lifestyle, free of stigma, with controlled blood sugar levels, and achieve their goals in life.
We are developing education and training programs for primary and secondary schools, making use of the Mass media, organizing fund-raising activities, conducting regular youth leadership training camps, and peer-to-peer counseling centers, developing microfinance support for further education, and cooperating with the Ministry of Health.”
Sarah E. Linklater (nรฉe Allan) PhD Canada Co-author
โThe Index provides much-needed definition to what has long been a blurry and incomplete picture on the global burden of T1D โ and the results are striking. Itโs been a privilege to contribute to this initiative, which will be a catalyst for countless initiatives aimed at improving and saving lives impacted by T1D.โ
“We are delighted to be able to contribute to the T1D index. I led the work on the recent systematic review on incidence of type 1 diabetes in adults for the IDF Diabetes Atlas. This highlighted the paucity of data on type 1 diabetes in adults, as well as the surprisingly high rates in late adulthood. The T1D index builds on the data collected from our systematic review, and provides a comprehensive estimate of the global burden of type 1 diabetes in different parts of the world. The T1D index highlights the urgent need to better identify adults presenting with diabetes who in fact have underlying T1D. It will no doubt be an invaluable resource for healthcare professionals as well as health organizations for advocacy and healthcare planning.”
“I was very excited to be involved in the generation of the T1D Index. Understanding the burden of type 1 diabetes for the world to date has been challenging. Such information is crucial, not only to increase the awareness of type 1 diabetes, but also to inform public health policy, improve ย delivery of care and ultimately the quality of life for people with type 1 diabetes.”
“As president-elect of the Brazilian Society of Diabetes (SBD) for the term 2020/2021, I was contacted by Breakthrough T1D’s senior staff Dr. Sanjoy Dutta in 2019 regarding the initiation of cooperative works between Breakthrough T1D and SBD. A meeting followed in 2020 with Mr. Mike Wilson, and arrangements were then made for development of the comprehensive Brazilian T1D epidemiological data by SBD. In 2021 I was honoured to coordinate an online workshop involving SBD’s Epidemiology Department and Breakthrough T1D’s T1D Index research staff, during which the updated Brazilian data were presented. A rich and hopefully lasting interchange followed between SBD and Breakthrough T1D.”
“Data helps paint pictures – vivid pictures that are easy to understand and connect with. The T1D Index is bringing to life – finally! – the challenges that people with Type 1 diabetes face all over the world. As a South African with Type 1, I’m excited to see how this can advance our advocacy efforts so that we can improve the lives of people with Type 1 in SA.”
Karla F S Melo, PhD in Endocrinology and Metabolism, Coordinator of the Public Health Department from the Brazilian Diabetes Society, Brazil
“It was an honor and a pleasure to contribute to the T1D Index, sharing information about Brazilian public health policies on diabetes, their results and ongoing initiatives. The data to be published in the T1D Index are very important for further elaboration of strategies to improve the health and quality of life of people with diabetes.”
โI wish to congratulate the authors of the T1D Index. This is the first such compilation internationally and shows the huge burden of type 1 diabetes in different parts of the world. I am particularly concerned that India has one of the largest numbers of T1D, both below, as well as, above 20 years of age. It is also worrying that the remaining life expectancy in those with T1D in India is only 24 years, compared to 69 years in Japan and 67 years in Australia. This points to the need for improving the control of T1D in developing countries like Indiaโ.
Dr Graham Ogle General Manager, Life for a Child Program Diabetes NSW, Australia Co-author
“I am delighted to have participated in the development of the T1D index. It is a truly novel initiative which will greatly assist advocacy, awareness, and resource allocation, and thereby potentially saving thousands of lives and extending the lives of tens of thousands more.”
“T1D Index is truly a groundbreakingย initiative that will change the face of T1D globally.ย I am very pleased and honoured to be part of this important work. Let’s take on T1D together!”
Professor Trevor J Orchard MD, M Med Sci, FAHA, FACE United States of America Co-author
“I was involved mainly in terms of the epidemiology input, particularly as regards consideration of mortality rates utilizing both our Pittsburgh data and that acquired in Rwanda. The index will allow, in addition to supplying ย essential health care planning needs, the recognition of the increasing burden of T1D in income challenged countries”
Christopher C Patterson Honorary Professor of Medical Statistics and Epidemiology, Queen’s University Belfast, United Kingdom
“The T1D Indexย incorporates welcome methodological developments whichย refine previous attempts to estimate worldwide numbers with type 1 diabetes.ย These include estimates made by colleagues and myselfย for childhood and adolescence inย the International Diabetes Federation Atlas and estimates for all age-groups made by a WHO working group. “
“The T1D Index is an ambitious global coalition that brings together researchers, advocates and people living with T1D from around the world. While the data is ground-breaking and reveals for the first time the significant global impact of T1D, it is the unprecedented collaboration that drives this work which is the most promising development for people everywhere who live with the condition. We hope this effort continues to shine a light on T1D and empower people and decision makers to act now and turn the tide of T1D.”
Professor Marian Rewers MD PhD United States of America
“I had the pleasure to review the United States T1D data for the Global T1D Index. The authors created a fantastic comprehensive global picture of T1D by showing the size and growth of T1D in countries around the world and how these numbers are changing over time.”
Tom Robinson VP Global Access, Breakthrough T1D Australia Co-author
โWe hope that these country-level modelling results will be used by policy makers, researchers, and healthcare professionals alike to build initiatives that improve surveillance of T1D worldwide and encourage Universal health coverage programs, so that T1D care is available and affordable to all, addressing the substantial global burden of this disease.โ
”ย I am thankful to Breakthrough T1D for choosing me as a spokesperson from India. T1D index is a huge work thatย showcases the importance of prompt diagnosis, access to insulin and test strips, self-management tools and access to technology. With this research work, further exploration canย beย done, which can help us restore the quality of life of everyone living with type 1 diabetes. This can change the numbers and stories.”
“The T1D Index is a truly remarkable resource, providing a clear picture of the impact of type 1 diabetes around the world, while also being a brilliant resource for diabetes grassroots and community advocacy. Iโm honoured to have contributed to discussions about communication and language. Congratulations to Breakthrough T1D for leading this important work.”
“As people living with diabetes, our voices are still very underrepresented in research. The T1D Index allows for us to be part of something bigger and we are also given the opportunity to be heard as the people living with the diabetes. Nothing about us without us!”
“Taking the first step, creating something from scratch, going from zero to one – is always the most challenging. What it yields is a foundation that others can build on and drive exponential growth. This is what we strongly believe at Diabesties, and I’m excited to see the same principle in action with the T1D Index. It is a much needed development that would allow governments, support organizations and broader stakeholders,ย to accurately understand the urgency that Type 1 Diabetes requires globally. As organisations and people living with the condition, we have continuously tried to raise the profile of T1D, but were missing this crucial piece of evidence. The T1D index captures poignant and powerful data which outlines key issues and metrics. I am confident that we would be able to use this data in multiple ways to improve the quality AND quantity of life for those living with T1D. The index not only helps understand the reality of disparity in access, but also serves as a tool to influence policy thatย can help make a meaningful and sustainable change. This comprehensive document is a major resource for the entire community and we at Diabesties, are grateful to be partners in this grand pursuit.”
โThe focus on early intervention and prevention is critical and the best way to understand the impact of a disease and its progression is to collect meaningful data. We are now in the position where we have a powerful tool to assist governments and the global community to act. These investments will have profound social, heath, and economic benefits for all of society.โ
โWe are extremely grateful to Breakthrough T1D for taking the leadership role in establishing the T1D Index which is going to provide tremendous visibility on the global picture as it relates to Type 1 Diabetes. As a result, we are convinced this will lead to a higher level of diagnosis, and enhanced ongoing treatment of the condition, ultimately leading to improved health outcomesย and saving hundreds and thousands of lives.โ
“The Index achieves a high degree of accuracy through the judicious application of the appropriate methodologies, effectively integrating conventional statistical approaches with advanced machine learning techniques. Anticipated access to an expanded and enhanced dataset, coupled with continuous refinement of our models, positions the Index for progressive improvement, enhancing its capacity to render a more detailed and precise representation of the T1D community. I take immense pride in my contribution to this comprehensive process.”
International Diabetes Federation Diabetes Atlas Type 1 Diabetes in Adults Special Interest Group
“We are delighted to be able to contribute to the T1D index. We conducted the recent systematic review on incidence of type 1 diabetes in adults for the IDF Diabetes Atlas. This highlighted the paucity of data on type 1 diabetes in adults, as well as the surprisingly high rates in late adulthood. The T1D index builds on the data collected from our systematic review, and provides a comprehensive estimate of the global burden of type 1 diabetes in different parts of the world. The T1D index highlights the urgent need to better identify adults presenting with diabetes who in fact have underlying T1D. It will no doubt be an invaluable resource for healthcare professionals as well as health organizations for advocacy and healthcare planning.”
T1D Index Champions
Henk-Jan Aanstoot, MD, PhD Pediatrician-diabetologist and clinical research Director Diabeter Netherlands
“T1D-Index is extremely important as it illustrates not only the size and impact of type 1 diabetes, ย but creates a solid scientific basis for a world-wide call for action. I am glad we could contributed and we will help to use the T1D-Index to improve outcomes and the lives of all people affected by T1D. “
Karen Addington CEO, Breakthrough T1D United Kingdom
“In this centenary year of theย first human life to be saved with the discovery of insulin, it is right that we put a spotlight on the global inequality of access in type 1 diabetes medicines and treatments.ย The T1D Index has been developed by Breakthrough T1D and partners to give all countries for the very first time trustworthy data on type 1 prevalence, predicted growth and the devastating health impact.ย It’s a vital new tool in our work to eradicate type 1 diabetes and we will be working with international leaders to help design more equitable global access to treatments.”
Silver Bahendeka, MBChB, MSc, Cert D&E; FRCPI, PhD Hon Senior Consultant Physician, St. Francis Hospital, Nsambya Kampala Hon Professor of Medicine, MKPGMS – Uganda Martyrs University, Kampala Chair, East Africa Diabetes Study Group (EADSG)
“The availability of the Type 1 Diabetes (T1D) Index is a wake-up call for the Low and Middle Income Countries (LMIC) that now there is a rich resource of data and tools to handle the epidemiology and quality management of T1D in these countries.”
Andrew JM Boulton, MD, DSc (Hon), FACP, FICP, FRCP, President, International Diabetes Federation Chair, EURADIA: Alliance for European Diabetes Research Professor of Medicine, University of Manchester and Visiting Professor, University of Miami, FL Consultant Physician, Manchester Royal Infirmary Past-President, European Association for the Study of Diabetes. United Kingdom
โAs President of the International Diabetes Federation, I am delighted that we are partnering with Breakthrough T1D and other organisations in the launch of our shared type 1 diabetes Index.ย Just a couple of years ago a review in a diabetes journal reported a high burden of illness for people living with type 1 diabetes concluding that significant investment in research and development of novel treatments for this condition are urgently needed.ย The T1D Index will help to clarify the type 1 diabetes burden and the collection of accurate data will help planning for those with type 1 diabetes in many countriesโ
“T1D Index is the result of huge effort to visualise the status of T1 diabetes worldwide. Data have never gone that far. I feel honored to have contributed to this amazing initiative and supported Breakthrough T1D to get access to the T1 diabetes community in Spain”
Dr Juliana Chizo Agwu Consultant Pediatrician in Diabetes and Endocrinology, Sandwell and West Birmingham NHS Trust, United Kingdom
“Although more children with diabetes are being diagnosed in sub-Saharan Africa, their outcome is poor and complications are high. The TID Index will help policy makers, NGO’sย and others direct aid where it will be most impactful.”
Nanette DeTurk Breakthrough T1D International Director Emirita United States of America
“Iโm excited about this credible data for the first time to zero in on T1D impact across the global. ย Iโm beyond thrilled about the future in extending the lives and health of all those living with this disease.”
Mark Fischer-Colbrie Former Chair, Breakthrough T1D International and volunteer Unites States of America
“This brilliant work will have an incalculable and global impact on the lives of those of type one diabetes and their families. As a 20 year volunteer and former Chairman of Breakthrough T1D, it is great to see this foundational work that will drive advances in public policy around the world.”
Claudia Graham, PhD, MPH Chair of the Advocacy & Impact Committee Member of the International Board of Directors, Breakthrough T1D, United States of America
“My involvement stems from the simple issue that unless Type 1 people have access to appropriate treatments, we are not helping to make life better for people with T1D.ย This index is the first solid step to highlighting where the inequities lie, and knowing where efforts can be focused.”
โImproved diabetes data will drive better outcomes for patients in all aspects of care. The T1D Index is an invaluable resource and will hopefully spark further T1D studies, especially within under-resourced countries.โ
Aaron Kowalski, PhD CEO, Breakthrough T1D International
โAs a member of the T1D community, I know many are not as fortunate as I am to have the resources necessary to live a healthy and fulfilled life. This is why I am so proud that significant progress has been made to understand T1Dโs global impact through the T1D Index. We are calling on government and public health decision makers throughout the world to utilize the tool to identify and implement interventions that can change the trajectory of T1D.โ
“After living in Ukraine in 2019 and noticing a lack of resources for Ukrainians with diabetes, Sina and I led a collaboration between T1D Index and the Ukrainian Student Association at Stanford to translate the T1D Index into Ukrainian. Not only is the T1D Index an accessible tool detailing how diabetes impacts people around the world, but it also provides critical information on how we can reduce these disparities to work towards a more equitable future.”
Nupur Lalvani Founder Director Blue Circle Diabetes Foundation, India
โThis is such a breakthrough in how we address T1D Globally (and Locally)! ย The T1D Index will increase awareness of the disease and its impact; will create action in more countries; and will improve lives for those living with T1D and their families.โ
โIn a global world, countries are both similar and different. The Global T1 Index us essential tool to provide data , information and ย identify the needs of people with diabetes, a first step in improving ย careโ
Dr Chantal Mathieu, PhD, Endocrinology Leuven Belgium
“Finally we will have a tool that maps T1D! Working on the disease for many years, having data on prevalence and other relevant issues is essential. In INNODIA, a project researching biomarkers of T1D and running clinical trials to arrest beta-cell destruction, we welcome this new initiative!”
Sina Mollaei Undergraduate student at Stanford University United States of America
โProviding this data to a global audience is an exciting step towards a world without diabetes. I look forward to seeing how the index gets utilized in the coming yearsโ
Vivian Nabeta Founder & Executive Director Sonia Nabeta Foundation United States of America
“It was great to see the demo and to have the opportunity to share my thoughts on the T1DIndex. I applaud the initiative and efforts as data is central to developing meaningful, contextualized and impactful interventions. SNF is looking forward to working with Breakthrough T1D to strengthen the health equity aspects of the index.”
“I am a person living with T1D for the past 20 years & I volunteer at the Blue Circle Diabetes Foundation. I believe that people living with Diabetes should be empowered with proper education & engagement with local communities to create safe spaces so that they are able to voice their opinions & views.”
Ann Sofie Westh Olsen, PhD Global Access to Care Lead Novo Nordisk Denmark
โWe hope that the Type 1 Index will help contribute to the wellbeing of children and youth across the world, by shining more light on the substantial global burden of this disease and improving healthcare policies, especially in Low and Middle Income countries.โ
Dorota Pawlak, PhD Chief Scientific Officer Breakthrough T1D Australia and Director Australian T1D Clinical Research Network, Australia
“Through the work of T1D Index we can now grasp the extraordinary burden of type 1 diabetes in every country across the globe. Action is now required across all sectors of medical and public health systems to lead the change.”
Margery Perry Past Chair of Research, Breakthrough T1D United States of America
“It is imperative that we all take note of this important work. ย We canโt alter what we canโt measure and lives depend on it. ย This Global effort will transform ย the way the world thinks about T1D. ย This is only the beginning of the changes that need to happen in order to save lives.”
“Having the first comprehensive global view of the scope and scale of type 1 diabetes means we can help more people, and bring more attention to this relentless condition.”
Derek Rapp Former CEO, Breakthrough T1D International and volunteer United States of America
โType 1 diabetes can be a devastating diagnosis at a personal level, and yet at a societal level, T1D has not been well understood. The T1D Index sheds light on the magnitude of T1Dโs impact globally which should lead to greater urgency to find improved therapies and even cures.โ
Lorne Shiff Breakthrough T1D International Director Emirita United States of America
“Having been involved with Breakthrough T1D for over 50 years, this effort is monumental. The index will saves lives around the world and that is what it is all about.”
“EUDF is proud to support the launch of the T1D Index. The T1D Index measures the human and public health impact of the T1D crisis in every country across the globe. EUDF will use these data and insights from the T1D index in our advocacy work with European policy makers. Greater awareness of the impact of T1D will help change the lives of people with T1D.”
Francesca Ulivi CEO, Fondazione Italiana Diabete Italy
“The T1D Index is the strongest and fundamental tool that will allow everyone advocating for the disease to be heard from institutions and general population, which is not affected. Type 1 diabetes has been confused and misunderstood for a long time, the consequences of the disease have been mostly underestimated, now, with the evidences so clearly presented in the T1D Index, it will be clear for everyone how T1D affects the life of everyone of us and our world.”
Beatrice Vetter, PhD Deputy Director NCDs, FIND Switzerland
โData from the T1D index will demonstrate to country decision makers how better access to diagnostics and self-monitoring tools can save health systems money and improve quality of life for people living with diabetes.โ
David Walton, Chief Executive Officer T1D Exchange, United States of America
“The T1D index is an incredibly rich and compelling dataset on T1D globally. We are excited to collaborate with the team to further advance understanding of the burden of the disease and what can be done to improve care.”
“The T1D Index will highlight to the world for the first time the true scale and burden of this disease globally. Such information will generate attention and demand investment, both of which are needed on our pathway towards eventually delivering a world without T1D”
If you or your organization are interested in becoming a T1D Index Champion or contributing to future releases, please reach out to us at hello@t1dindex.org
We are working on making this site accessible to everyone around the globe. If you would like to help us in our efforts to translate the site, please contact us on hello@t1dindex.org